Literature DB >> 2203613

Inflammatory markers in bronchoalveolar lavage and in bronchial biopsy in asthma during remission.

A Foresi1, G Bertorelli, A Pesci, A Chetta, D Olivieri.   

Abstract

Bronchoalveolar lavage and BB were performed in 13 asthmatic and six healthy subjects to characterize cellular markers of inflammation in BAL and BB; to compare cellular profile of BAL with cell infiltration in BB; to examine the relationship between bronchial responsiveness and markers of inflammation in BAL and BB. Eosinophils and mast cells were increased in BAL in asthmatic subjects; eosinophils were positively correlated with neutrophils and mast cells. Epithelial shedding was present in nine asthmatic and five control subjects. Intraepithelial cells and cells in submucosa were increased in asthmatic subjects. Eosinophils and intraepithelial mast cells were higher. Thickened basement membrane was associated with more marked cell infiltration in submucosa. Ciliated cells in BAL relate to intraepithelial cells; cells in BAL broadly reflect cell infiltration of submucosa. In the asthmatic group, the degree of bronchial responsiveness correlated with ciliated cells in BAL and with intra-epithelial cells in BB. Marked airway inflammation is associated with stable asthma; inflammatory changes within bronchial epithelium may be linked to the development of bronchial hyperresponsiveness.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2203613     DOI: 10.1378/chest.98.3.528

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

Review 1.  Airway hyperresponsiveness in asthma: not just a matter of airway inflammation.

Authors:  V Brusasco; E Crimi; R Pellegrino
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

Review 2.  Importance of mast cells in the pathophysiology of asthma.

Authors:  Seong H Cho; Andrea J Anderson; Chad K Oh
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

Review 3.  Variability of inflammatory cell counts on bronchial biopsies of normal subjects.

Authors:  H Turcotte; M Laviolette; M Boutet; L-P Boulet
Journal:  Lung       Date:  2003       Impact factor: 2.584

Review 4.  Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond.

Authors:  David A Medina-Tato; Stephen G Ward; Malcolm L Watson
Journal:  Immunology       Date:  2007-08       Impact factor: 7.397

Review 5.  Redox control of asthma: molecular mechanisms and therapeutic opportunities.

Authors:  Suzy A A Comhair; Serpil C Erzurum
Journal:  Antioxid Redox Signal       Date:  2010-01       Impact factor: 8.401

6.  Kinetics of eosinophilia and eosinophil activation in the development of non-allergic bronchial hyperresponsiveness in guinea pigs injected with Sephadex beads.

Authors:  K Maghni; M J Simard; D Arseneault; P Sirois
Journal:  Inflammation       Date:  1996-10       Impact factor: 4.092

7.  Inhibition by new glucocorticoid antedrugs [16α, 17α-d] isoxazoline and [16α, 17α-d]-3'-hydroxy-iminoformyl isoxazoline derivatives of chemotaxis and CCL26, CCL11, IL-8, and RANTES secretion.

Authors:  Younes J Errahali; Leeshawn D Thomas; Thomas C S Keller; Henry J Lee
Journal:  J Interferon Cytokine Res       Date:  2013-05-16       Impact factor: 2.607

Review 8.  Allergy and the lung.

Authors:  G Passalacqua; G Ciprandi
Journal:  Clin Exp Immunol       Date:  2008-09       Impact factor: 4.330

Review 9.  Mast cell-mediated and associated disorders in pregnancy: a risky game with an uncertain outcome?

Authors:  Katja Woidacki; Ana Claudia Zenclussen; Frank Siebenhaar
Journal:  Front Immunol       Date:  2014-05-19       Impact factor: 7.561

10.  Storage conditions for stability of offline measurement of fractional exhaled nitric oxide after collection for epidemiologic research.

Authors:  Yoshiko Yoda; Naruhito Otani; Hideki Hasunuma; Hiroshi Kanegae; Masayuki Shima
Journal:  BMC Pulm Med       Date:  2012-11-02       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.